

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.49229647 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 6.88968580 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 6.27058563 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 6.27058563 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.27058563 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.27058563 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.27058563 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 6.27058563 |
| 9 | negative regulation of cell killing (GO:0031342) | 5.83612450 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.83612450 |
| 11 | respiratory burst (GO:0045730) | 5.28972494 |
| 12 | detection of other organism (GO:0098543) | 5.24557622 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 5.08255019 |
| 14 | detection of external biotic stimulus (GO:0098581) | 4.99869152 |
| 15 | response to peptidoglycan (GO:0032494) | 4.86508849 |
| 16 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.82676604 |
| 17 | negative regulation of interleukin-12 production (GO:0032695) | 4.80595472 |
| 18 | granulocyte activation (GO:0036230) | 4.78469748 |
| 19 | detection of bacterium (GO:0016045) | 4.75598001 |
| 20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.73448640 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 4.68808201 |
| 22 | neutrophil activation (GO:0042119) | 4.60045606 |
| 23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.56701226 |
| 24 | superoxide anion generation (GO:0042554) | 4.55752758 |
| 25 | positive regulation of interferon-alpha production (GO:0032727) | 4.52481796 |
| 26 | detection of biotic stimulus (GO:0009595) | 4.48455043 |
| 27 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.47789061 |
| 28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.43929783 |
| 29 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 4.41263809 |
| 30 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.36328312 |
| 31 | reactive oxygen species biosynthetic process (GO:1903409) | 4.32459997 |
| 32 | regulation of interferon-alpha production (GO:0032647) | 4.25200120 |
| 33 | response to host immune response (GO:0052572) | 4.20286798 |
| 34 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.20286798 |
| 35 | regulation of gamma-delta T cell activation (GO:0046643) | 4.19034155 |
| 36 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.17952052 |
| 37 | positive regulation of mast cell activation (GO:0033005) | 4.08373166 |
| 38 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.07081701 |
| 39 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.05176783 |
| 40 | positive regulation of mast cell degranulation (GO:0043306) | 4.05176783 |
| 41 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.02642519 |
| 42 | myeloid cell activation involved in immune response (GO:0002275) | 4.02325189 |
| 43 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.97459280 |
| 44 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.89237990 |
| 45 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.83822536 |
| 46 | microglial cell activation (GO:0001774) | 3.77841918 |
| 47 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.77658723 |
| 48 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.75847242 |
| 49 | regulation of mast cell degranulation (GO:0043304) | 3.72789564 |
| 50 | eosinophil chemotaxis (GO:0048245) | 3.72715650 |
| 51 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.72329870 |
| 52 | natural killer cell mediated immunity (GO:0002228) | 3.70952008 |
| 53 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.70952008 |
| 54 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.67492855 |
| 55 | response to host (GO:0075136) | 3.67492855 |
| 56 | response to host defenses (GO:0052200) | 3.67492855 |
| 57 | cellular response to zinc ion (GO:0071294) | 3.66990321 |
| 58 | regulation of mononuclear cell migration (GO:0071675) | 3.63165986 |
| 59 | negative regulation of T cell mediated immunity (GO:0002710) | 3.61712018 |
| 60 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.60717947 |
| 61 | macrophage activation (GO:0042116) | 3.60319286 |
| 62 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.58290623 |
| 63 | myeloid leukocyte mediated immunity (GO:0002444) | 3.55705150 |
| 64 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.55630790 |
| 65 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.53849919 |
| 66 | regulation of mast cell activation (GO:0033003) | 3.52287240 |
| 67 | phagosome maturation (GO:0090382) | 3.50069152 |
| 68 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.48829560 |
| 69 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.48006628 |
| 70 | regulation of monocyte chemotaxis (GO:0090025) | 3.44876963 |
| 71 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.44777305 |
| 72 | myeloid dendritic cell differentiation (GO:0043011) | 3.43496009 |
| 73 | response to interleukin-15 (GO:0070672) | 3.42861026 |
| 74 | detection of molecule of bacterial origin (GO:0032490) | 3.42786770 |
| 75 | eosinophil migration (GO:0072677) | 3.40794556 |
| 76 | response to muramyl dipeptide (GO:0032495) | 3.40279222 |
| 77 | positive regulation of macrophage cytokine production (GO:0060907) | 3.38904989 |
| 78 | positive regulation of interferon-beta production (GO:0032728) | 3.38877216 |
| 79 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.37487178 |
| 80 | B cell mediated immunity (GO:0019724) | 3.36902455 |
| 81 | negative regulation of interleukin-17 production (GO:0032700) | 3.36271430 |
| 82 | leukocyte mediated cytotoxicity (GO:0001909) | 3.35356254 |
| 83 | regulation of tolerance induction (GO:0002643) | 3.35053993 |
| 84 | positive regulation of leukocyte degranulation (GO:0043302) | 3.32070231 |
| 85 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.30057354 |
| 86 | regulation of T cell tolerance induction (GO:0002664) | 3.29296622 |
| 87 | positive regulation of antigen processing and presentation (GO:0002579) | 3.28867332 |
| 88 | wound healing, spreading of epidermal cells (GO:0035313) | 3.24128549 |
| 89 | myeloid dendritic cell activation (GO:0001773) | 3.23128964 |
| 90 | cellular extravasation (GO:0045123) | 3.22838540 |
| 91 | regulation of cholesterol storage (GO:0010885) | 3.21280829 |
| 92 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.19841646 |
| 93 | cellular response to interleukin-15 (GO:0071350) | 3.16837831 |
| 94 | B cell receptor signaling pathway (GO:0050853) | 3.16798985 |
| 95 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.14852949 |
| 96 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.14757065 |
| 97 | regulation of leukocyte degranulation (GO:0043300) | 3.14164810 |
| 98 | T-helper 1 type immune response (GO:0042088) | 3.12921226 |
| 99 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.12717919 |
| 100 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.12496182 |
| 101 | myeloid leukocyte activation (GO:0002274) | 3.11322522 |
| 102 | leukocyte aggregation (GO:0070486) | 3.09886628 |
| 103 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.09183069 |
| 104 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.08943893 |
| 105 | monocyte chemotaxis (GO:0002548) | 3.08938445 |
| 106 | leukocyte degranulation (GO:0043299) | 3.07534471 |
| 107 | negative regulation of mast cell activation (GO:0033004) | 3.05986694 |
| 108 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.03975117 |
| 109 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.03665300 |
| 110 | dendritic cell migration (GO:0036336) | 3.03316433 |
| 111 | dendritic cell differentiation (GO:0097028) | 2.99807549 |
| 112 | regulation of chemokine biosynthetic process (GO:0045073) | 2.99569780 |
| 113 | positive regulation of interleukin-12 production (GO:0032735) | 2.99511646 |
| 114 | activated T cell proliferation (GO:0050798) | 2.99483746 |
| 115 | neutrophil chemotaxis (GO:0030593) | 2.98918010 |
| 116 | positive thymic T cell selection (GO:0045059) | 2.94389217 |
| 117 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.93775393 |
| 118 | regulation of B cell differentiation (GO:0045577) | 2.92788446 |
| 119 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.91768367 |
| 120 | lymphocyte chemotaxis (GO:0048247) | 2.91619039 |
| 121 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.91613915 |
| 122 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.91313223 |
| 123 | negative thymic T cell selection (GO:0045060) | 2.90653332 |
| 124 | neutrophil migration (GO:1990266) | 2.90616877 |
| 125 | germinal center formation (GO:0002467) | 2.88996640 |
| 126 | positive regulation of B cell differentiation (GO:0045579) | 2.88830557 |
| 127 | cellular response to exogenous dsRNA (GO:0071360) | 2.88080052 |
| 128 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.83562597 |
| 129 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.83076253 |
| 130 | positive regulation of type 2 immune response (GO:0002830) | 2.82656342 |
| 131 | neutrophil mediated immunity (GO:0002446) | 2.82400719 |
| 132 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.82365509 |
| 133 | type I interferon signaling pathway (GO:0060337) | 2.80067527 |
| 134 | cellular response to type I interferon (GO:0071357) | 2.80067527 |
| 135 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.79730089 |
| 136 | lymphocyte mediated immunity (GO:0002449) | 2.79229755 |
| 137 | response to type I interferon (GO:0034340) | 2.78542181 |
| 138 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.78290859 |
| 139 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.77423437 |
| 140 | regulation of antigen processing and presentation (GO:0002577) | 2.76749708 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.08376743 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.39679356 |
| 3 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.28123339 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.70624317 |
| 5 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.48620063 |
| 6 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.28664808 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.93101804 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.76462741 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.39615642 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.22268728 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.21224815 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.17599748 |
| 13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.91456834 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.82697008 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.66571287 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.62656730 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.58101763 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.38835740 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.23388572 |
| 20 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.14934089 |
| 21 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.10034274 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.06146261 |
| 23 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.04445400 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.91736861 |
| 25 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.90835073 |
| 26 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.85889162 |
| 27 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.85121188 |
| 28 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.82974185 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.81848187 |
| 30 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.78501120 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.75586619 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61649084 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.58680242 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.56473756 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55768576 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.55205028 |
| 37 | MYB_26560356_Chip-Seq_TH2_Human | 1.53288591 |
| 38 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.52998731 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.50687377 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.49801546 |
| 41 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42544489 |
| 42 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41395090 |
| 43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40662280 |
| 44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.35288857 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29347855 |
| 46 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.28302312 |
| 47 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.28302312 |
| 48 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.27905575 |
| 49 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.26872668 |
| 50 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.25697121 |
| 51 | MAF_26560356_Chip-Seq_TH2_Human | 1.23235189 |
| 52 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21200831 |
| 53 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21057344 |
| 54 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20441083 |
| 55 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19896433 |
| 56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19096498 |
| 57 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.18693059 |
| 58 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17570999 |
| 59 | MAF_26560356_Chip-Seq_TH1_Human | 1.16866964 |
| 60 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.15861726 |
| 61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15124883 |
| 62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14618518 |
| 63 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12821840 |
| 64 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10828881 |
| 65 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07660659 |
| 66 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07028370 |
| 67 | MYB_26560356_Chip-Seq_TH1_Human | 1.06876069 |
| 68 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05799186 |
| 69 | MYC_22102868_ChIP-Seq_BL_Human | 1.03519035 |
| 70 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.03182746 |
| 71 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02617349 |
| 72 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.01089619 |
| 73 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00477020 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.00296952 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98012383 |
| 76 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.97217665 |
| 77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96891716 |
| 78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96602960 |
| 79 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95905520 |
| 80 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.94369745 |
| 81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94344335 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93273254 |
| 83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91179612 |
| 84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90519609 |
| 85 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.90148954 |
| 86 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.89860518 |
| 87 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89589953 |
| 88 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87941935 |
| 89 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87561390 |
| 90 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87223654 |
| 91 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.79735687 |
| 92 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.79221067 |
| 93 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.78918511 |
| 94 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.78755487 |
| 95 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.78356501 |
| 96 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.75969221 |
| 97 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.75683982 |
| 98 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75178292 |
| 99 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74804382 |
| 100 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72796921 |
| 101 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.70925010 |
| 102 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.70852274 |
| 103 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70594887 |
| 104 | UTX_26944678_Chip-Seq_JUKART_Human | 0.70449375 |
| 105 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.70115224 |
| 106 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.69920429 |
| 107 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.69648612 |
| 108 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.69161141 |
| 109 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.69161141 |
| 110 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.68940499 |
| 111 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.67910908 |
| 112 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.66987005 |
| 113 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.65779096 |
| 114 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.64048422 |
| 115 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.63826411 |
| 116 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.63669201 |
| 117 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.63018307 |
| 118 | GATA3_26560356_Chip-Seq_TH1_Human | 0.62966199 |
| 119 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.62916819 |
| 120 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.62267394 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.62132175 |
| 122 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.61902656 |
| 123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.61830428 |
| 124 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.60427266 |
| 125 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.60285242 |
| 126 | GATA1_22025678_ChIP-Seq_K562_Human | 0.60127319 |
| 127 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.58766346 |
| 128 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.56900033 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.00049274 |
| 2 | MP0003436_decreased_susceptibility_to | 4.36445432 |
| 3 | MP0003303_peritoneal_inflammation | 4.02193464 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.82402731 |
| 5 | MP0009785_altered_susceptibility_to | 3.65705292 |
| 6 | MP0006082_CNS_inflammation | 3.63873035 |
| 7 | * MP0002419_abnormal_innate_immunity | 3.43224739 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.31464698 |
| 9 | MP0003724_increased_susceptibility_to | 3.11551722 |
| 10 | MP0005058_abnormal_lysosome_morphology | 3.06224110 |
| 11 | * MP0005025_abnormal_response_to | 2.99372223 |
| 12 | MP0004510_myositis | 2.83966207 |
| 13 | * MP0002452_abnormal_antigen_presenting | 2.65350603 |
| 14 | MP0005671_abnormal_response_to | 2.50064198 |
| 15 | MP0001790_abnormal_immune_system | 2.44697235 |
| 16 | MP0005387_immune_system_phenotype | 2.44697235 |
| 17 | * MP0002723_abnormal_immune_serum | 2.41904563 |
| 18 | MP0001800_abnormal_humoral_immune | 2.27187363 |
| 19 | MP0001853_heart_inflammation | 2.24362089 |
| 20 | * MP0001819_abnormal_immune_cell | 2.18243412 |
| 21 | MP0000685_abnormal_immune_system | 2.16771839 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.16257948 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.14759412 |
| 24 | * MP0002420_abnormal_adaptive_immunity | 2.13328615 |
| 25 | MP0009764_decreased_sensitivity_to | 2.06736674 |
| 26 | MP0002405_respiratory_system_inflammati | 2.05857207 |
| 27 | MP0003172_abnormal_lysosome_physiology | 2.03363393 |
| 28 | MP0003075_altered_response_to | 1.97915230 |
| 29 | MP0003448_altered_tumor_morphology | 1.97186287 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.93564705 |
| 31 | MP0000343_altered_response_to | 1.92192873 |
| 32 | * MP0001845_abnormal_inflammatory_respons | 1.84315370 |
| 33 | MP0005310_abnormal_salivary_gland | 1.76445510 |
| 34 | MP0005166_decreased_susceptibility_to | 1.75200211 |
| 35 | MP0003690_abnormal_glial_cell | 1.73288136 |
| 36 | MP0002998_abnormal_bone_remodeling | 1.69496001 |
| 37 | MP0008469_abnormal_protein_level | 1.67737796 |
| 38 | MP0003763_abnormal_thymus_physiology | 1.65377813 |
| 39 | MP0002132_abnormal_respiratory_system | 1.60446751 |
| 40 | MP0004947_skin_inflammation | 1.59975588 |
| 41 | MP0004782_abnormal_surfactant_physiolog | 1.57706835 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.54738223 |
| 43 | MP0009840_abnormal_foam_cell | 1.48716338 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.46348405 |
| 45 | MP0000716_abnormal_immune_system | 1.46153992 |
| 46 | MP0000569_abnormal_digit_pigmentation | 1.42521237 |
| 47 | MP0002006_tumorigenesis | 1.42249964 |
| 48 | MP0000858_altered_metastatic_potential | 1.41859707 |
| 49 | MP0000604_amyloidosis | 1.36844508 |
| 50 | MP0004381_abnormal_hair_follicle | 1.36636405 |
| 51 | MP0003186_abnormal_redox_activity | 1.27406053 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 1.26637434 |
| 53 | MP0003828_pulmonary_edema | 1.24897902 |
| 54 | MP0002398_abnormal_bone_marrow | 1.23776652 |
| 55 | MP0001851_eye_inflammation | 1.17307522 |
| 56 | MP0002396_abnormal_hematopoietic_system | 1.15478078 |
| 57 | MP0005164_abnormal_response_to | 1.14954947 |
| 58 | MP0002429_abnormal_blood_cell | 1.13348511 |
| 59 | MP0005174_abnormal_tail_pigmentation | 1.12661970 |
| 60 | MP0009278_abnormal_bone_marrow | 1.12239328 |
| 61 | MP0000703_abnormal_thymus_morphology | 1.09892477 |
| 62 | MP0008260_abnormal_autophagy | 1.09071961 |
| 63 | MP0002254_reproductive_system_inflammat | 1.07734617 |
| 64 | MP0001545_abnormal_hematopoietic_system | 1.06080152 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 1.06080152 |
| 66 | MP0002138_abnormal_hepatobiliary_system | 1.05403659 |
| 67 | MP0010386_abnormal_urinary_bladder | 1.03106502 |
| 68 | MP0000689_abnormal_spleen_morphology | 1.03080886 |
| 69 | MP0005390_skeleton_phenotype | 1.01186918 |
| 70 | MP0003300_gastrointestinal_ulcer | 0.96526670 |
| 71 | MP0002722_abnormal_immune_system | 0.94903891 |
| 72 | MP0008004_abnormal_stomach_pH | 0.94259738 |
| 73 | MP0002277_abnormal_respiratory_mucosa | 0.93049564 |
| 74 | MP0005257_abnormal_intraocular_pressure | 0.91565711 |
| 75 | MP0002090_abnormal_vision | 0.90656402 |
| 76 | MP0000920_abnormal_myelination | 0.89760586 |
| 77 | MP0003183_abnormal_peptide_metabolism | 0.88548747 |
| 78 | MP0002933_joint_inflammation | 0.87590172 |
| 79 | * MP0009763_increased_sensitivity_to | 0.85610897 |
| 80 | MP0004883_abnormal_blood_vessel | 0.83759592 |
| 81 | MP0005075_abnormal_melanosome_morpholog | 0.82200285 |
| 82 | MP0002166_altered_tumor_susceptibility | 0.80951196 |
| 83 | MP0001986_abnormal_taste_sensitivity | 0.80371379 |
| 84 | MP0003566_abnormal_cell_adhesion | 0.79991099 |
| 85 | MP0005076_abnormal_cell_differentiation | 0.79694786 |
| 86 | MP0000249_abnormal_blood_vessel | 0.78906326 |
| 87 | MP0003806_abnormal_nucleotide_metabolis | 0.78789045 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 0.78716430 |
| 89 | MP0010307_abnormal_tumor_latency | 0.77044253 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 0.75206498 |
| 91 | MP0003795_abnormal_bone_structure | 0.75125483 |
| 92 | MP0005451_abnormal_body_composition | 0.74903002 |
| 93 | MP0000371_diluted_coat_color | 0.72905245 |
| 94 | MP0003045_fibrosis | 0.71304875 |
| 95 | MP0000015_abnormal_ear_pigmentation | 0.70925756 |
| 96 | MP0010352_gastrointestinal_tract_polyps | 0.70901752 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.68495480 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.65946393 |
| 99 | MP0004484_altered_response_of | 0.64538811 |
| 100 | MP0004130_abnormal_muscle_cell | 0.63361474 |
| 101 | MP0003705_abnormal_hypodermis_morpholog | 0.63215287 |
| 102 | MP0006054_spinal_hemorrhage | 0.62473956 |
| 103 | MP0004808_abnormal_hematopoietic_stem | 0.62017349 |
| 104 | * MP0001663_abnormal_digestive_system | 0.60774334 |
| 105 | MP0008874_decreased_physiological_sensi | 0.59372227 |
| 106 | MP0003221_abnormal_cardiomyocyte_apopto | 0.57827596 |
| 107 | MP0003329_amyloid_beta_deposits | 0.56047226 |
| 108 | MP0002332_abnormal_exercise_endurance | 0.55591450 |
| 109 | MP0003787_abnormal_imprinting | 0.54619325 |
| 110 | MP0005388_respiratory_system_phenotype | 0.54229482 |
| 111 | MP0002133_abnormal_respiratory_system | 0.54229482 |
| 112 | MP0002295_abnormal_pulmonary_circulatio | 0.53362612 |
| 113 | MP0000465_gastrointestinal_hemorrhage | 0.51819859 |
| 114 | MP0005376_homeostasis/metabolism_phenot | 0.51637622 |
| 115 | MP0000372_irregular_coat_pigmentation | 0.51314731 |
| 116 | MP0008873_increased_physiological_sensi | 0.50423468 |
| 117 | MP0003866_abnormal_defecation | 0.47762886 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.47431994 |
| 119 | MP0003279_aneurysm | 0.47059762 |
| 120 | MP0000767_abnormal_smooth_muscle | 0.46883140 |
| 121 | MP0001958_emphysema | 0.46816930 |
| 122 | MP0005319_abnormal_enzyme/_coenzyme | 0.46751523 |
| 123 | MP0000490_abnormal_crypts_of | 0.46008685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 8.62126609 |
| 2 | Recurrent abscess formation (HP:0002722) | 8.14542008 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 7.95846280 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 7.53773451 |
| 5 | Abnormality of macrophages (HP:0004311) | 6.06318875 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 5.21075103 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 5.15400319 |
| 8 | Gingivitis (HP:0000230) | 4.87137672 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 4.85762238 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 4.45414764 |
| 11 | Obstructive lung disease (HP:0006536) | 4.45414764 |
| 12 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.41433682 |
| 13 | Axonal loss (HP:0003447) | 4.35170519 |
| 14 | Disinhibition (HP:0000734) | 4.21391100 |
| 15 | * Recurrent skin infections (HP:0001581) | 4.00520030 |
| 16 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.95426462 |
| 17 | Orchitis (HP:0100796) | 3.93950103 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 3.91103861 |
| 19 | Stomatitis (HP:0010280) | 3.88325099 |
| 20 | Myositis (HP:0100614) | 3.83335068 |
| 21 | Systemic lupus erythematosus (HP:0002725) | 3.79445658 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.77338919 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.77338919 |
| 24 | Abnormality of glycolipid metabolism (HP:0010969) | 3.77338919 |
| 25 | Optic neuritis (HP:0100653) | 3.72471974 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 3.72471974 |
| 27 | Encephalitis (HP:0002383) | 3.72309199 |
| 28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.68733826 |
| 29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.67628994 |
| 30 | * Recurrent fungal infections (HP:0002841) | 3.48064752 |
| 31 | T lymphocytopenia (HP:0005403) | 3.42721613 |
| 32 | Interstitial pulmonary disease (HP:0006530) | 3.37015876 |
| 33 | Cellulitis (HP:0100658) | 3.35894106 |
| 34 | Basal ganglia calcification (HP:0002135) | 3.33960989 |
| 35 | Chest pain (HP:0100749) | 3.31796202 |
| 36 | Agnosia (HP:0010524) | 3.26162435 |
| 37 | * Hemoptysis (HP:0002105) | 3.18189939 |
| 38 | Prostate neoplasm (HP:0100787) | 3.15104785 |
| 39 | Vasculitis (HP:0002633) | 3.11687868 |
| 40 | Amyloidosis (HP:0011034) | 3.07183669 |
| 41 | Periodontitis (HP:0000704) | 3.06481127 |
| 42 | Urticaria (HP:0001025) | 3.04512878 |
| 43 | Episodic fever (HP:0001954) | 3.01297465 |
| 44 | Dysostosis multiplex (HP:0000943) | 2.99505439 |
| 45 | Peritonitis (HP:0002586) | 2.98631400 |
| 46 | Myocardial infarction (HP:0001658) | 2.92898890 |
| 47 | * Chronic mucocutaneous candidiasis (HP:0002728) | 2.90912609 |
| 48 | * Recurrent cutaneous fungal infections (HP:0011370) | 2.90912609 |
| 49 | Pulmonary embolism (HP:0002204) | 2.88156334 |
| 50 | Prolonged bleeding time (HP:0003010) | 2.88011738 |
| 51 | Recurrent pneumonia (HP:0006532) | 2.84337274 |
| 52 | Increased IgE level (HP:0003212) | 2.81215843 |
| 53 | Hepatosplenomegaly (HP:0001433) | 2.79890011 |
| 54 | Recurrent viral infections (HP:0004429) | 2.78449632 |
| 55 | Joint hemorrhage (HP:0005261) | 2.77422264 |
| 56 | Osteomyelitis (HP:0002754) | 2.75329206 |
| 57 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.72237391 |
| 58 | Meningitis (HP:0001287) | 2.64972849 |
| 59 | Abnormality of T cells (HP:0002843) | 2.64027327 |
| 60 | Pulmonary infiltrates (HP:0002113) | 2.63342419 |
| 61 | Increased IgM level (HP:0003496) | 2.62699469 |
| 62 | Abnormality of the pleura (HP:0002103) | 2.61484870 |
| 63 | Thick nail (HP:0001805) | 2.61193697 |
| 64 | Upper motor neuron abnormality (HP:0002127) | 2.58759637 |
| 65 | Pustule (HP:0200039) | 2.52562481 |
| 66 | Glomerulonephritis (HP:0000099) | 2.49893427 |
| 67 | Hypochromic microcytic anemia (HP:0004840) | 2.46910268 |
| 68 | Loss of speech (HP:0002371) | 2.44043804 |
| 69 | Hypochromic anemia (HP:0001931) | 2.40063640 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.36680008 |
| 71 | Poor head control (HP:0002421) | 2.35932953 |
| 72 | Recurrent lower respiratory tract infections (HP:0002783) | 2.34834937 |
| 73 | Abnormality of the peritoneum (HP:0002585) | 2.32509797 |
| 74 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.31753291 |
| 75 | Mucopolysacchariduria (HP:0008155) | 2.31753291 |
| 76 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.30459421 |
| 77 | Gingival bleeding (HP:0000225) | 2.30459030 |
| 78 | Vertigo (HP:0002321) | 2.30324461 |
| 79 | Arterial thrombosis (HP:0004420) | 2.29525006 |
| 80 | Leukocytosis (HP:0001974) | 2.29473979 |
| 81 | Nausea (HP:0002018) | 2.27216090 |
| 82 | Glomerulopathy (HP:0100820) | 2.26493468 |
| 83 | Panhypogammaglobulinemia (HP:0003139) | 2.24252486 |
| 84 | Bone pain (HP:0002653) | 2.24161637 |
| 85 | Granulocytopenia (HP:0001913) | 2.22321705 |
| 86 | Polyneuropathy (HP:0001271) | 2.21735536 |
| 87 | Hypergammaglobulinemia (HP:0010702) | 2.20321407 |
| 88 | Gastrointestinal inflammation (HP:0004386) | 2.19161111 |
| 89 | Inappropriate behavior (HP:0000719) | 2.18154674 |
| 90 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.14526999 |
| 91 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.14526999 |
| 92 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.14526999 |
| 93 | Keratitis (HP:0000491) | 2.13371500 |
| 94 | Keratoconjunctivitis sicca (HP:0001097) | 2.10467466 |
| 95 | Eosinophilia (HP:0001880) | 2.10433734 |
| 96 | Pathologic fracture (HP:0002756) | 2.10069365 |
| 97 | Petechiae (HP:0000967) | 2.09660058 |
| 98 | Premature loss of primary teeth (HP:0006323) | 2.07952228 |
| 99 | Abnormality of T cell physiology (HP:0011840) | 2.07589987 |
| 100 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.03842682 |
| 101 | Sepsis (HP:0100806) | 2.02627682 |
| 102 | Peripheral demyelination (HP:0011096) | 2.01362317 |
| 103 | Acne (HP:0001061) | 2.00529551 |
| 104 | Amaurosis fugax (HP:0100576) | 1.97689436 |
| 105 | Purpura (HP:0000979) | 1.97387016 |
| 106 | * Abnormality of the endocardium (HP:0004306) | 1.97092103 |
| 107 | Progressive visual loss (HP:0000529) | 1.96528295 |
| 108 | Chronic otitis media (HP:0000389) | 1.94200966 |
| 109 | Tetraparesis (HP:0002273) | 1.93560332 |
| 110 | Hematochezia (HP:0002573) | 1.92765829 |
| 111 | Spontaneous hematomas (HP:0007420) | 1.92430453 |
| 112 | Keratoconjunctivitis (HP:0001096) | 1.91130515 |
| 113 | Microcytic anemia (HP:0001935) | 1.91058128 |
| 114 | Abnormality of the pericardium (HP:0001697) | 1.90846066 |
| 115 | Acute hepatic failure (HP:0006554) | 1.89528104 |
| 116 | Viral hepatitis (HP:0006562) | 1.88582221 |
| 117 | Colitis (HP:0002583) | 1.88501795 |
| 118 | Thrombophlebitis (HP:0004418) | 1.88165690 |
| 119 | Increased serum ferritin (HP:0003281) | 1.88020226 |
| 120 | Gastrointestinal infarctions (HP:0005244) | 1.88011257 |
| 121 | Anorexia (HP:0002039) | 1.87835035 |
| 122 | Nephritis (HP:0000123) | 1.87117758 |
| 123 | Albinism (HP:0001022) | 1.86751564 |
| 124 | Abnormality of the prostate (HP:0008775) | 1.84927524 |
| 125 | Bone cyst (HP:0012062) | 1.83851300 |
| 126 | Lymphopenia (HP:0001888) | 1.83158846 |
| 127 | Arthralgia (HP:0002829) | 1.81814307 |
| 128 | Diminished motivation (HP:0000745) | 1.80946174 |
| 129 | * Skin ulcer (HP:0200042) | 1.80712756 |
| 130 | Recurrent bronchitis (HP:0002837) | 1.80568698 |
| 131 | Abnormality of iron homeostasis (HP:0011031) | 1.80118484 |
| 132 | J-shaped sella turcica (HP:0002680) | 1.80028501 |
| 133 | Osteolytic defects of the hand bones (HP:0009699) | 1.79862316 |
| 134 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.79862316 |
| 135 | Abnormality of the lumbar spine (HP:0100712) | 1.79379297 |
| 136 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.79185391 |
| 137 | Gangrene (HP:0100758) | 1.78637198 |
| 138 | Abnormality of T cell number (HP:0011839) | 1.77524372 |
| 139 | Epistaxis (HP:0000421) | 1.75907962 |
| 140 | Apathy (HP:0000741) | 1.73314440 |
| 141 | Conjunctival telangiectasia (HP:0000524) | 1.71496639 |
| 142 | Menorrhagia (HP:0000132) | 1.71019465 |
| 143 | Personality changes (HP:0000751) | 1.70896452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 5.19421257 |
| 2 | RIPK4 | 5.04362955 |
| 3 | BLK | 4.04330840 |
| 4 | MAP3K14 | 3.90036495 |
| 5 | IRAK4 | 3.16724788 |
| 6 | TBK1 | 3.10207557 |
| 7 | IRAK3 | 2.76865089 |
| 8 | TYK2 | 2.53977098 |
| 9 | MAP4K1 | 2.34741249 |
| 10 | IKBKB | 2.19181689 |
| 11 | ERN1 | 2.17479250 |
| 12 | PIM2 | 2.03709260 |
| 13 | IKBKE | 1.97800368 |
| 14 | GRK6 | 1.92288841 |
| 15 | TNK2 | 1.87155268 |
| 16 | KIT | 1.86197546 |
| 17 | TXK | 1.82891278 |
| 18 | ABL2 | 1.81959112 |
| 19 | JAK1 | 1.81454844 |
| 20 | CSK | 1.66642848 |
| 21 | JAK3 | 1.64703948 |
| 22 | NME2 | 1.61620865 |
| 23 | PRPF4B | 1.53856672 |
| 24 | MST4 | 1.46718491 |
| 25 | EPHB1 | 1.45905408 |
| 26 | MST1R | 1.45245881 |
| 27 | FGR | 1.39176453 |
| 28 | SYK | 1.36774920 |
| 29 | NEK9 | 1.34425491 |
| 30 | HCK | 1.31140655 |
| 31 | MATK | 1.30861719 |
| 32 | TAOK1 | 1.29050077 |
| 33 | BMX | 1.25997828 |
| 34 | TGFBR2 | 1.24280566 |
| 35 | ERBB3 | 1.24255695 |
| 36 | JAK2 | 1.20433107 |
| 37 | CHUK | 1.19967300 |
| 38 | LYN | 1.18429390 |
| 39 | BMPR2 | 1.18214997 |
| 40 | TRPM7 | 1.18103536 |
| 41 | GRK7 | 1.17099668 |
| 42 | MAP3K13 | 1.16850741 |
| 43 | RPS6KA4 | 1.15429423 |
| 44 | ZAP70 | 1.12762924 |
| 45 | EPHA3 | 1.11427598 |
| 46 | TAOK3 | 1.09386028 |
| 47 | STK4 | 1.02883682 |
| 48 | BTK | 1.01678059 |
| 49 | PIK3CG | 1.00862334 |
| 50 | TEC | 1.00549886 |
| 51 | CSF1R | 1.00202394 |
| 52 | IRAK1 | 0.99189965 |
| 53 | PIM1 | 0.98958022 |
| 54 | CLK1 | 0.95130093 |
| 55 | CAMKK2 | 0.93820228 |
| 56 | LCK | 0.93277441 |
| 57 | YES1 | 0.91602425 |
| 58 | MARK3 | 0.80746395 |
| 59 | FRK | 0.80126244 |
| 60 | PRKCD | 0.78145165 |
| 61 | FGFR3 | 0.76607238 |
| 62 | MARK2 | 0.76555177 |
| 63 | IRAK2 | 0.75786717 |
| 64 | CDK19 | 0.75524087 |
| 65 | STK10 | 0.71639799 |
| 66 | MAP3K11 | 0.70137254 |
| 67 | MAP3K6 | 0.69807273 |
| 68 | PTK2B | 0.69745726 |
| 69 | ACVR1B | 0.69438071 |
| 70 | ABL1 | 0.69227806 |
| 71 | MAP2K3 | 0.67408101 |
| 72 | EGFR | 0.67221454 |
| 73 | FES | 0.66764089 |
| 74 | EIF2AK2 | 0.62950019 |
| 75 | KSR1 | 0.61190925 |
| 76 | SGK3 | 0.60413047 |
| 77 | MAP2K4 | 0.58547155 |
| 78 | SGK2 | 0.58123111 |
| 79 | ARAF | 0.57521087 |
| 80 | STK11 | 0.57429408 |
| 81 | MAPK7 | 0.57007341 |
| 82 | TRIB3 | 0.55706051 |
| 83 | ADRBK2 | 0.55654673 |
| 84 | FGFR4 | 0.54921846 |
| 85 | MAPK12 | 0.54187884 |
| 86 | ITK | 0.52479705 |
| 87 | MAP3K5 | 0.52382990 |
| 88 | WNK1 | 0.51888002 |
| 89 | PRKD2 | 0.49735306 |
| 90 | RAF1 | 0.49508267 |
| 91 | MAP3K7 | 0.48932944 |
| 92 | SIK2 | 0.48495364 |
| 93 | STK24 | 0.48163159 |
| 94 | MAP3K1 | 0.46676850 |
| 95 | MAP2K6 | 0.46558118 |
| 96 | MAP3K12 | 0.45437765 |
| 97 | RIPK1 | 0.44013010 |
| 98 | PRKCQ | 0.43974588 |
| 99 | LRRK2 | 0.43591249 |
| 100 | MAP3K3 | 0.43287845 |
| 101 | DYRK1B | 0.42826469 |
| 102 | STK3 | 0.41957487 |
| 103 | CDC42BPA | 0.40975945 |
| 104 | CAMKK1 | 0.40099688 |
| 105 | MAP3K2 | 0.39999221 |
| 106 | HIPK2 | 0.38756910 |
| 107 | BMPR1B | 0.38536637 |
| 108 | NLK | 0.38492681 |
| 109 | MOS | 0.37776589 |
| 110 | ERBB4 | 0.37721686 |
| 111 | SCYL2 | 0.35468276 |
| 112 | RPS6KL1 | 0.35397592 |
| 113 | CAMK1D | 0.34779242 |
| 114 | CDK6 | 0.34717867 |
| 115 | KSR2 | 0.34457201 |
| 116 | RPS6KA6 | 0.34231010 |
| 117 | CAMK4 | 0.34164916 |
| 118 | FYN | 0.33953874 |
| 119 | DAPK3 | 0.32305933 |
| 120 | RET | 0.31957733 |
| 121 | PDGFRB | 0.31873185 |
| 122 | TAOK2 | 0.31787115 |
| 123 | PTK6 | 0.30205347 |
| 124 | DYRK3 | 0.29593047 |
| 125 | DAPK2 | 0.29203000 |
| 126 | TESK1 | 0.29032619 |
| 127 | PRKCZ | 0.27812084 |
| 128 | MAP3K10 | 0.27557486 |
| 129 | MAPKAPK2 | 0.27204092 |
| 130 | TTN | 0.25439983 |
| 131 | PDPK1 | 0.25177089 |
| 132 | PDK1 | 0.24459378 |
| 133 | SIK3 | 0.24042429 |
| 134 | INSR | 0.23590894 |
| 135 | RPS6KC1 | 0.22242484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.57902452 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.02756149 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.01581223 |
| 4 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.81109174 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.74471426 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.66244350 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.61495708 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.59174283 |
| 9 | * Tuberculosis_Homo sapiens_hsa05152 | 2.55028734 |
| 10 | * Phagosome_Homo sapiens_hsa04145 | 2.40405340 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.37695198 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.35226745 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 2.32168238 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.32092203 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.17286121 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 2.11534853 |
| 17 | Asthma_Homo sapiens_hsa05310 | 2.02172703 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.93574450 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.88951870 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.87092329 |
| 21 | Salmonella infection_Homo sapiens_hsa05132 | 1.85798367 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.82156121 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.69547234 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.65023620 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.59309278 |
| 26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.57560003 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.57214177 |
| 28 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.54687384 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.52605672 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.51291145 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.50760240 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.47018675 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46221355 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.45326545 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.41238244 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.40862554 |
| 37 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.34256073 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.30762009 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.25501787 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.25036054 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.22062499 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21447497 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.13607239 |
| 44 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.09694360 |
| 45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.08376851 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.03867659 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 0.97531929 |
| 48 | Amoebiasis_Homo sapiens_hsa05146 | 0.96414009 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96302397 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 0.96250736 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96180361 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.95379268 |
| 53 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90276733 |
| 54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.90162707 |
| 55 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86707557 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 0.85742169 |
| 57 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82336761 |
| 58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78797189 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77364377 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71169527 |
| 61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.67114428 |
| 62 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.66528371 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66241364 |
| 64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.64681687 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 0.63787262 |
| 66 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63698140 |
| 67 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.58733067 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57404920 |
| 69 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56673650 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55351953 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.55030607 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51943835 |
| 73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50964736 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50236942 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48326545 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48097146 |
| 77 | Mineral absorption_Homo sapiens_hsa04978 | 0.47850641 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47829980 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46602564 |
| 80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45613298 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45609584 |
| 82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44521117 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42710344 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41695365 |
| 85 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41467928 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38377156 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37697026 |
| 88 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37298236 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37232421 |
| 90 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.37106454 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33760202 |
| 92 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.33601037 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33166761 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32834489 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32598104 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32552884 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32302855 |
| 98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31274657 |
| 99 | Endocytosis_Homo sapiens_hsa04144 | 0.30828684 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30281284 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29813625 |
| 102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.29517149 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.27750891 |
| 104 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.27619426 |
| 105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.26792518 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.26211508 |
| 107 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.26159018 |
| 108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25426125 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.23534910 |
| 110 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.22358890 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.21396890 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.19954972 |
| 113 | Histidine metabolism_Homo sapiens_hsa00340 | 0.19907102 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.17778073 |
| 115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.16732894 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.13119960 |
| 117 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.11937114 |
| 118 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.07876258 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.07405521 |

